Prognostic Factors of Ado-Trastuzumab Emtansine Treatment in Patients With Metastatic HER-2 Positive Breast Cancer

Deniz Tataroğlu Özyükseler,Mustafa Basak,Seval Ay,Aygul koseoglu,Serdar Arici,Abdilkerim Oyman,Heves Surmeli,Merve Turan,Nedim Turan,Hatice Odabas,Mahmut E Yıldırım

Prognostic Factors of Ado-Trastuzumab Emtansine Treatment in Patients With Metastatic HER-2 Positive Breast Cancer

2020

Deniz Tataroğlu Özyükseler
Mustafa Basak
Seval Ay
Aygul koseoglu
Serdar Arici
Abdilkerim Oyman
Heves Surmeli
Merve Turan
Nedim Turan
Hatice Odabas
Mahmut E Yıldırım

BackgroundAdo-trastuzumab emtansine is an antibody-drug conjugate that combines the cytotoxic activity of emtansine with human epidermal growth factor receptor 2-targeted antitumor features of tras...

Keywords:

Oncology
Cytotoxic T cell
Medicine
Internal medicine
Metastatic breast cancer
Trastuzumab emtansine
Breast cancer
Ado-trastuzumab emtansine
Human Epidermal Growth Factor Receptor 2
human epidermal growth factor receptor
Anesthesia
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations